Evidence map›Paper›PMID 39375755›Full record

ArticleParasites & vectors2024

Exploring transmission dynamics of the Sarcoptes scabiei mite in humans by combining molecular typing and epidemiological variables, the Netherlands 2016-2023.

Martijn Vink, Hester Coppoolse, Anneke Bergmans, Meike Wennekes, Suzan Pas, Jane Pattipeilohy-van Ommen, Marieta Braks, Sylvia Bruisten, Annemie Galimont-Collen, Bas Wintermans and 1 more

Abstract read
In one paragraph

Article in Parasites & vectors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Martijn Vink *Department of Infectious Diseases, Public Health Service (GGD) of Rotterdam-Rijnmond, Rotterdam, the Netherlands.
Hester Coppoolse *Department of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, the Netherlands. hcoppoolse@ggd.amsterdam.nl.
Anneke BergmansMedical Microbiology & Immunology Brabant & Zeeland (Microvida), Roosendaal, the Netherlands.
Meike WennekesMedical Microbiology & Immunology Brabant & Zeeland (Microvida), Roosendaal, the Netherlands.
Suzan PasDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Jane Pattipeilohy-van OmmenDepartment of Infectious Diseases, Public Health Service (GGD) of Utrecht, Zeist, the Netherlands.
Marieta BraksCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Sylvia BruistenDepartment of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, the Netherlands.
Annemie Galimont-CollenDepartment of Dermatology, Bravis Hospital, Roosendaal, the Netherlands.
Bas WintermansMedical Microbiology & Immunology Brabant & Zeeland (Microvida), Roosendaal, the Netherlands.
Ewout FanoyDepartment of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScabies, an infestation of the mite Sarcoptes scabiei, has seen an increase in clinical diagnoses in the Netherlands since 2011. This study aimed to analyse PCR-positive S. scabiei skin samples through partial genome sequencing and to link findings to patient epidemiological characteristics.

methodsSkin samples were collected from individuals in the Netherlands between January 2016 and January 2023. On the PCR-positive S. scabiei skin samples, partial mitochondrial cytochrome c oxidase subunit 1 gene (cox1) sequencing was performed to assess genetic variability. Epidemiological information was collected through interviews. We examined associations between cox1 subtypes, epidemiological factors and treatment outcomes.

resultsSequencing results were obtained from 128 patients, with epidemiological information available for 55 (43%) of these patients. Fifteen distinct cox1 subtypes were identified. Subtype 01 was most prevalent (45%) and present across all age groups and social settings. The remaining subtypes were less common and not consistently found in all contexts. Five clusters were identified, each with identical cox1 subtypes. Comparative analysis with GenBank sequences revealed genetic similarities with strains from Australia, the USA and China, suggesting the global distribution and transmission of specific subtypes. A substantial proportion (73%) of patients with scabies required multiple treatments to eradicate the infestation, with no subtype-related differences.

conclusionsThis is the first study linking S. scabiei sequencing results to patient epidemiological data. Several subtypes clustered in specific geographic regions and social contexts, underscoring localised transmission patterns. Further research with larger sample sizes is needed to enhance our understanding of the transmission of this mite. This study provides valuable insights that will strengthen scabies control efforts.

Indexed as

Sarcoptes scabieiScabiesAdolescentAdultAgedAged, 80 and overAnimalsChildChild, PreschoolElectron Transport Complex IVFemaleGenetic VariationHumansInfantMaleMiddle AgedElectron Transport Complex IVcox1Cytochrome cMiteMolecular typingSarcoptes scabieiScabies

Identifiers

PMID39375755
PMCPMC11459799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.